Boehringer Ingelheim Initiates SPRING Study Of Aptivus(R) (tipranavir) Capsules In Diverse Group Of - Details

Link Details 

+ Articles ON » Listing Details

User Menu

» Articles Home
» Submit Article Link
» Submit Feed
» Latest Articles
» Top Articles



Statistics

Categories: 160
Subcategories: 0
Total Posts/Links: 3622
Pending: 1
Today: 0


Sponsors


» BlogsON
» Law Blogs
» A-Law Directory
» Hukuki Net law
» Webdeweb





ID:548
Title:Boehringer Ingelheim Initiates SPRING Study Of Aptivus(R) (tipranavir) Capsules In Diverse Group Of - http://www.medicalnewstoday.com/medicalnews.php?newsid=74241&nfid=crss
Description:Boehringer Ingelheim Pharmaceuticals, Inc., makers of Aptivus(R) (tipranavir) capsules, announced today that it has begun to enroll patients in the SPRING study. The goal of the SPRING study, which will be conducted at 72 sites across eight countries, is to enroll 200 women and 200 men who are HIV-positive and highly treatment- experienced. [click link for full article]
Category:Aids
Link Owner:
Date Added:June 15, 2007 02:00:00 PM
Number Hits:0
 
RSS Feed